News | September 03, 2023
Shilpa Medicare receives UK MHRA approval for mouth-dissolving strips to treat illnesses
This approval has come from the company's finished dosage form manufacturing facility
This approval has come from the company's finished dosage form manufacturing facility
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
Subscribe To Our Newsletter & Stay Updated
